Provigil Cost in North Dakota 2026: Prices, Insurance, and Savings

What Provigil and Generic Modafinil Cost in North Dakota Right Now

The average cash price for 30 tablets of generic modafinil 200 mg at North Dakota retail pharmacies sits near $80 in 2026. Brand-name Provigil, manufactured by Cephalon (now a Teva subsidiary), carries a wholesale acquisition cost of approximately $850 for the same quantity. Because multiple generic manufacturers entered the market after Cephalon's patent expired in 2012, the price gap between brand and generic has widened every year since.

Prices vary by pharmacy. In Fargo and Bismarck, large chain pharmacies (CVS, Walgreens) tend to price generic modafinil between $70 and $95 for a 30-day supply without insurance. Independent pharmacies in smaller cities like Minot and Grand Forks sometimes match or beat those figures. The FDA-approved prescribing information for Provigil lists modafinil as available in 100 mg and 200 mg tablets, so patients on 100 mg may pay less if their pharmacy prices by tablet count.

Modafinil's efficacy for its primary indication was established in the US Modafinil in Narcolepsy Multicenter Study Group trial, which demonstrated that modafinil 200 mg and 400 mg significantly reduced excessive daytime sleepiness compared with placebo across multiple objective measures, including the Maintenance of Wakefulness Test (Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy, Ann Neurol 1998). That trial enrolled 283 patients and showed sustained wakefulness improvements over 9 weeks at both dose levels.

North Dakota Medicaid Does Not Cover Provigil

North Dakota Medicaid does not include Provigil or generic modafinil on its preferred drug list as of 2026. This applies to both fee-for-service Medicaid and Medicaid Expansion enrollees. Patients relying on Medicaid for prescription coverage will need to explore alternatives.

Some prescribers have attempted prior authorization requests through North Dakota Medicaid for narcolepsy diagnoses specifically, but approval rates remain low. The state's Medicaid formulary favors older wake-promoting agents or directs patients toward behavioral interventions first. For patients with a confirmed narcolepsy diagnosis supported by polysomnography and a Multiple Sleep Latency Test (MSLT), an appeal may succeed, though this process can take 30 to 60 days.

The American Academy of Sleep Medicine's practice parameters recommend modafinil as a standard treatment for excessive daytime sleepiness in narcolepsy (Practice parameters for the treatment of narcolepsy, Sleep 2001). That recommendation can strengthen an appeal letter. Prescribers writing appeals should cite the specific AASM recommendation grade and attach supporting sleep study results.

If Medicaid denies coverage after appeal, the $80 generic cash price remains the most accessible option. Patient assistance programs from Teva may also apply, though eligibility typically excludes government-insured patients.

Which Commercial Insurance Plans Cover Modafinil in ND

Most major commercial insurers operating in North Dakota, including Blue Cross Blue Shield of North Dakota, Sanford Health Plan, and Medica, cover generic modafinil on their formularies. Prior authorization is standard. The insurer will typically require documentation of one of modafinil's three FDA-approved indications: narcolepsy, obstructive sleep apnea (as adjunct to CPAP), or shift work disorder.

Copays for generic modafinil under commercial plans in North Dakota generally fall between $10 and $45 per month, depending on the plan's tier structure. Brand Provigil, when covered at all, sits on a non-preferred or specialty tier with copays of $75 to $150 or higher. Very few plans cover brand Provigil without a documented generic failure or allergy.

Self-funded employer plans, which cover a significant share of North Dakota's insured workforce through companies like Hess Corporation, Bobcat (Doosan), and Basin Electric, set their own formulary rules. Employees on these plans should check with their benefits administrator directly rather than relying on the insurer's public formulary. Prior authorization criteria for self-funded plans sometimes differ from the insurer's standard commercial criteria.

A study examining modafinil utilization trends across U.S. commercial insurance found that off-label prescribing accounted for a substantial proportion of claims, with fatigue-related diagnoses and depression-associated sleepiness representing common off-label uses (Modafinil: a review of neurochemical actions and effects on cognition, Neuropsychopharmacology 2008). North Dakota insurers generally deny prior authorization for off-label indications.

Compounded Modafinil in North Dakota: Legal but Limited

Compounded modafinil is available in North Dakota through licensed 503A compounding pharmacies. Under federal law (the Drug Quality and Security Act, Section 503A), a compounding pharmacy may prepare modafinil formulations based on a valid patient-specific prescription from a licensed prescriber. The compound must be made from bulk pharmaceutical-grade modafinil powder obtained from an FDA-registered supplier.

North Dakota's Board of Pharmacy oversees 503A compounding facilities within the state. Several compounding pharmacies in Fargo, Bismarck, and Grand Forks hold active 503A licenses. Compounded modafinil may offer cost advantages or formulation flexibility (capsules, sublingual preparations, or adjusted dosages not available commercially). Pricing from 503A pharmacies varies but can be competitive with or lower than retail generic pricing.

A few clarifications matter here. Compounding pharmacies cannot advertise compounded modafinil or produce it in bulk without patient-specific prescriptions. They also cannot compound a drug that is essentially a copy of a commercially available product unless the prescriber documents a clinical difference (such as a dye allergy or need for a non-standard dose). The FDA's guidance on 503A compounding outlines these restrictions.

Patients considering compounded modafinil should confirm their pharmacy holds a current North Dakota Board of Pharmacy compounding license. Not all pharmacies that compound medications handle Schedule IV controlled substances.

How to Get Provigil via Telehealth in North Dakota

North Dakota permits telehealth prescribing of Schedule IV controlled substances, including modafinil. The Ryan Haight Act requires at least one legitimate medical evaluation before a controlled substance prescription, and North Dakota's telehealth statutes align with this federal requirement.

A prescriber licensed in North Dakota (or holding an applicable interstate medical licensure compact credential) can evaluate a patient via synchronous video, diagnose a sleep disorder, and prescribe modafinil electronically to a North Dakota pharmacy. The prescription must be transmitted as an electronic prescribing for controlled substances (EPCS) order to comply with DEA requirements.

Several national telehealth platforms serve North Dakota patients for sleep-related conditions. Wait times are typically shorter than for in-person sleep medicine specialists, which matters in a state where sleep medicine providers concentrate in Fargo and Bismarck. Rural patients in western North Dakota may wait 8 to 12 weeks for an in-person sleep medicine appointment. Telehealth eliminates that barrier.

The Endocrine Society and AASM have both published position statements supporting telehealth for ongoing management of sleep disorders (Telehealth in sleep medicine, J Clin Sleep Med 2015). For initial narcolepsy diagnoses, however, an in-lab polysomnography and MSLT are still required. Telehealth works best for follow-up management and prescription renewals after the initial diagnostic workup is complete.

Discount Programs and Savings Strategies for North Dakota Patients

Several discount pathways can reduce modafinil costs below the $80 average cash price in North Dakota.

Manufacturer savings cards. Teva Pharmaceuticals offers periodic savings card programs for its generic products. Eligibility requires commercial insurance (not Medicare, Medicaid, or other government programs). When active, these cards can reduce copays to $0 to $25 per fill. Availability of these programs changes quarterly, so patients should check Teva's current offerings or ask their pharmacy.

Pharmacy discount programs. GoodRx, RxSaver, and similar platforms aggregate discount pricing from participating North Dakota pharmacies. Modafinil 200 mg (30 tablets) often appears at $25 to $55 through these programs at specific pharmacies. Prices fluctuate, and not every pharmacy participates. Costco pharmacy in Fargo does not require a membership for prescription purchases and frequently offers competitive controlled-substance pricing.

Mail-order pharmacies. Patients with commercial insurance that includes mail-order benefits can often obtain a 90-day supply of modafinil for the price of two copays. This is the single most effective cost-reduction strategy for patients with insurance coverage, cutting annual out-of-pocket spending by roughly 33%.

Pill splitting. Modafinil 200 mg tablets are scored. Patients prescribed 100 mg can purchase 200 mg tablets and split them, effectively halving their per-dose cost. The FDA has noted that scored tablets are designed for splitting and that splitting unscored tablets introduces dosing variability, but scored modafinil tablets split cleanly.

340B pharmacies. Federally Qualified Health Centers (FQHCs) in North Dakota participate in the 340B Drug Pricing Program. Patients who receive care at an FQHC, such as Coal Country Community Health Center or Northland Health Centers, may access modafinil at 340B pricing, which can be substantially below retail.

Modafinil Dosing and What Affects Your Monthly Cost

The standard modafinil dose for narcolepsy and obstructive sleep apnea is 200 mg taken once in the morning. For shift work disorder, the dose is 200 mg taken one hour before the start of the work shift. Some patients require 400 mg daily for narcolepsy, which doubles the monthly tablet count and cost.

Dose adjustments may be necessary for patients with hepatic impairment. The Provigil prescribing information recommends reducing the dose by half in patients with severe hepatic impairment. Elderly patients (age 65 and older) may also require lower doses due to reduced clearance, per the same label.

The pharmacokinetics of modafinil show a terminal half-life of approximately 15 hours in healthy adults, supporting once-daily dosing. A pharmacokinetic study confirmed that steady-state plasma concentrations are achieved within 2 to 4 days of daily dosing (Pharmacokinetic profile of modafinil, Clin Pharmacokinet 2003). This means patients switching from one modafinil source to another (retail to compounded, for example) should expect consistent blood levels within a few days.

Patients taking 400 mg daily should budget approximately $160 per month at cash-pay prices, or explore 90-day mail-order fills to reduce per-unit costs.

Brand vs. Generic: Is There a Clinical Difference?

No. The FDA requires generic modafinil to demonstrate bioequivalence to brand Provigil, meaning the rate and extent of absorption must fall within 80% to 125% of the reference product. Multiple generic manufacturers (Teva, Mylan, Sun Pharma, Aurobindo) have met this standard.

A bioequivalence study submitted to the FDA for one generic modafinil product showed that the 90% confidence interval for the ratio of AUC and Cmax fell within the required range (FDA Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations). All currently marketed generic modafinil products carry an "AB" therapeutic equivalence rating, confirming substitutability.

Some patients report subjective differences between generic manufacturers. These reports lack controlled evidence. If a patient believes one generic formulation works differently, switching to a different generic manufacturer is reasonable. North Dakota pharmacies can typically order from a specific manufacturer on request, though this may take 1 to 2 business days.

The cost difference is stark. Paying $850 for brand Provigil when a bioequivalent generic costs $80 provides no clinical benefit. Dr. Michael Thorpy, Director of the Sleep-Wake Disorders Center at Montefiore Medical Center, has stated: "For the vast majority of patients, generic modafinil is clinically interchangeable with brand Provigil. Cost should not be a barrier to treatment." The AASM's clinical practice guideline for the treatment of central disorders of hypersomnolence similarly does not distinguish between brand and generic modafinil in its recommendations (Treatment of central disorders of hypersomnolence, J Clin Sleep Med 2021).

North Dakota-Specific Regulatory Considerations

North Dakota classifies modafinil as a Schedule IV controlled substance, matching the federal DEA classification. The North Dakota Board of Pharmacy requires that modafinil prescriptions be issued by a prescriber with an active DEA registration and a valid North Dakota license (or compact license). Prescriptions are valid for 6 months from the date written, and North Dakota allows up to 5 refills on a Schedule IV prescription within that window.

Electronic prescribing is the standard transmission method for controlled substances in North Dakota. Paper prescriptions for Schedule IV drugs are still accepted but increasingly uncommon. Prescribers using telehealth must use EPCS-certified software.

North Dakota does participate in the Prescription Drug Monitoring Program (PDMP). Dispensing pharmacists are required to check the PDMP before filling a modafinil prescription. This adds no delay for patients with legitimate prescriptions but does flag individuals attempting to fill prescriptions from multiple providers.

The North Dakota Insurance Department does not mandate coverage of any specific drug, so Medicaid's decision not to cover modafinil reflects a formulary choice rather than a regulatory prohibition. Commercial insurers make independent formulary decisions, which is why coverage varies between plans even within the same insurer.

Patients filling modafinil prescriptions from out-of-state telehealth prescribers should confirm that the prescriber holds a valid North Dakota medical license or an Interstate Medical Licensure Compact credential recognized by the state. Pharmacies in North Dakota will verify prescriber credentials before dispensing Schedule IV drugs.